Shuttle Pharmaceuticals Holdings, Inc.
$0.99
▲
12.86%
2026-04-21 09:24:01
www.shuttlepharma.com
NCM: SHPH
Explore Shuttle Pharmaceuticals Holdings, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$5.7 M
Current Price
$0.99
52W High / Low
$11.25 / $0.5
Stock P/E
—
Book Value
$1.13
Dividend Yield
—
ROCE
-791.36%
ROE
-7.91%
Face Value
—
EPS
$-7.16
Exp Qtr EPS
—
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
2
Beta
0.72
Debt / Equity
10.3
Current Ratio
0.06
Quick Ratio
0.06
Forward P/E
—
Price / Sales
—
Enterprise Value
$3.81 M
EV / EBITDA
-0.33
EV / Revenue
—
Rating
None
Target Price
—
EPS Forecast (FY)
—
Pros
- Short-term liquidity looks comfortable.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Leverage is relatively high.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Aytu BioPharma, Inc. | $2.58 | — | $27.69 M | — | 4.15% | -1.09% | $3.06 / $0.98 | $1.32 |
| 2. | Collegium Pharmaceutical, Inc. | $34.31 | 17.33 | $1.09 B | — | 14.67% | 23.7% | $50.79 / $25.86 | $9.51 |
| 3. | Phibro Animal Health Corporation | $56.51 | 24.91 | $2.29 B | 0.85% | 10.35% | 31.8% | $60.08 / $16.16 | $8.2 |
| 4. | Cronos Group Inc. | $2.76 | — | $1.4 B | — | -1.7% | -0.26% | $4.66 / $2.35 | $2.87 |
| 5. | Cumberland Pharmaceuticals Inc. | $3.15 | — | $47.57 M | — | -6.97% | -12.17% | $6.27 / $1.85 | $1.66 |
| 6. | Talphera, Inc. | $0.78 | — | $40.17 M | — | -52.04% | -1.15% | $1.57 / $0.38 | $0.34 |
| 7. | China Pharma Holdings, Inc. | $0.67 | — | $26.84 M | — | -46.43% | -20.91% | $2.6 / $0.5 | $1.47 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 0 M | 0 M | 0 M | 0 M | 0 M | — |
| Operating Profit | -2.79 M | -2.27 M | -3.91 M | -2.95 M | -1.78 M | — |
| Net Profit | -2.61 M | -2.35 M | -3.71 M | -3.05 M | -1.6 M | — |
| EPS in Rs | -0.47 | -0.42 | -0.66 | -0.55 | -0.29 | -39.83 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 0 M | 0 M | 0 M | 0 M |
| Operating Profit | -11.92 M | -7.7 M | -5.89 M | -2.34 M |
| Net Profit | -11.72 M | -9.14 M | -6.59 M | -5 M |
| EPS in Rs | -2.1 | -1.64 | -1.18 | -0.89 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 10.48 M | 2.51 M | 5.95 M | 8.65 M |
| Total Liabilities | 8.22 M | 1.8 M | 1.9 M | 0.98 M |
| Equity | 2.25 M | 0.71 M | 4.06 M | 7.68 M |
| Current Assets | 0.5 M | 2.21 M | 5.59 M | 8.58 M |
| Current Liabilities | 7.97 M | 1.53 M | 1.04 M | 0.98 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -9.48 M | -7.33 M | -5.58 M | -2.67 M |
| Investing CF | -3.06 M | 2.92 M | -2.83 M | 0 M |
| Financing CF | 10.95 M | 3.76 M | 2.57 M | 10.58 M |
| Free CF | -12.54 M | -7.33 M | -5.6 M | -2.67 M |
| Capex | -3.06 M | — | -0.02 M | — |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | — | — | — | — |
| Earnings Growth % | -38.71% | -31.96% | — | — |
| Profit Margin % | — | — | — | — |
| Operating Margin % | — | — | — | — |
| Gross Margin % | — | — | — | — |
| EBITDA Margin % | — | — | — | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
| Date | Split |
|---|---|
| 2025-06-16 | 1:0.04 |
| 2024-08-13 | 1:0.125 |